This is an open access article under the terms of the Creat ive Commo ns Attri bution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. Taken together, these findings advance the understanding of mechanism associated with HBx and AFB1-induced hepatic necrosome formation, mitochondrial dysfunction and steatosis and make COX-2 a good candidate for treatment.
| INTRODUC TI ON
Hepatic steatosis, characterized by aberrant accumulation of lipid droplets (LDs), is suggested to be a prerequisite and cofactor for fatty liver disease and subsequent hepatic injury, such as inflammation, fibrosis, cirrhosis and hepatocellular carcinoma (HCC). In addition to the genetic and diet-related factors, multiple epidemic studies suggested that hepatic steatosis was common in patient with chronic hepatitis B virus (HBV) infection.
1 Hepatitis B virus X protein (HBx) is a multifunctional protein encoded by HBV genome. It was reported that HBx trigged lipid accumulation in hepatocytes by increasing de novo lipogenesis and fatty acid (FA) uptake. 2, 3 However, there was a cross-sectional population study in Hong Kong demonstrated that HBV infection was associated with a lower prevalence of non-alcoholic fatty liver disease (NAFLD) and hypertriglyceridemia. 4 This observation agreed with a prior data from Taiwan indicating that HBV-infected patients had reduced serum triglyceride (TG). 5 Whether HBV infection correlated with the development of hepatic steatosis is still controversial, and the role of HBx in it remains to be elucidated. Apart from HBV, the liver is a target organ of aflatoxin B1 (AFB1), one of mycotoxin found in the human foods. Exposure to AFB1 had been shown to affect some pathogenic events implicated in hepatic lipid homoeostasis.
For example, exposure to 0.5 and 1 mg/kg of AFB1 for 7 days induced liver damage and dysregulation of genes associated with lipid metabolism in rats. 6 Notably, HBV-infected patients would be more susceptible to liver injury induced by AFB1. 7 However, just one study in zebrafish showed that combination of HBx and AFB1 promoted hepatic steatosis and increased the expression of lipogenic factors and genes related to lipid metabolism yet. 8 It is necessary to further determine the combined impact of HBx and AFB1 exposure on hepatic lipid homoeostasis and the potential mechanisms.
Increasing number of studies suggested that alterations of mitochondrial energetic metabolism were the initiating event in the development and progression of hepatic steatosis. 9 Thus, fatty liver disease has been considered as a mitochondrial related disease.
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Moreover, mitochondria are considered to be one of cell death executor and several pathways of programmed cell death are involved in regulating liver homoeostasis. 11 Necroptosis, a mode of programmed cell death, is involved in the development of NAFLD. 12 Although aberrant mitochondrial dynamics and function were served as crucial pathophysiological factors in HBV-infected hepatocytes 13 and AFB1
could also impair mitochondrial functions, 14 study addressing the interactive relations of mitochondrial dysfunction and necroptosis in AFB1 exposure and/or HBV infection-driven hepatic steatosis is lacking up to now.
Interestingly, our previous study showed that cyclooxygenase-2 (COX-2) promoted mitochondrial translocation of dynaminrelated protein 1 (Drp1), an important mediator of mitochondrial fission, resulting in a higher percentage of fragmented mitochondria in the cancer stem cells. 15 In spite of the extremely low expression in the liver, COX-2 can be induced by a variety of extracellular and intracellular stimuli, including reactive oxygen species, chemicals and viral infections. 16 Higher expression of COX-2 was observed in patients with clinical diagnosis of NAFLD than those in subjects with histologically normal liver. 17 More importantly, knocking down of COX-2 with small interfering RNA for prostaglandin-endoperoxide synthase 2 gene (PTGS2) encoding COX-2 (siPTGS2) or selective COX-2 inhibitor celecoxib ameliorated steatosis in palmitate-treated hepatocytes and in liver of high-fat dietfed rats, 18 highlighting that COX-2 should be a key regulator in the development of NAFLD. As we known, higher expression of COX-2 was shown in the hepatocytes of HBV-infected patients, even in patients with antiviral therapies. 19 HBx decreased mitochondrial membrane potential and ATP, and up-regulated COX-2 in vitro.
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Moreover, the expression of COX-2 was also increased in the liver of AFB1-treated rats and chicken. 21, 22 Therefore, there seemed to be a close, yet not totally understood, and complex interaction among COX-2, mitochondrial dysfunction, necrosome formation and lipid accumulation in hepatocytes co-exposed to HBx and AFB1. And the aim of this study was to figure out whether HBx and AFB1 could act in concert to activate COX-2, subsequently alter mitochondrial dynamics and facilitate necrosome formation, which ultimately trigger hepatic steatosis.
| MATERIAL S AND ME THODS

| Cell culture and treatment
Three HBx-expressing cell lines including HepG2. Material and methods).
| Animals and treatment
All of the animal experiments were performed in accordance with the guidelines of the Xiamen University Institutional Committee for the according to Azuma's methods. 24 FRG male mice were infected with HBV derived from the supernatant of HepaAD38 cells for 6 weeks.
Then, PHHs were isolated from the mice and exposed to 1 μmol/L of AFB1 for 48 or 72 hours. The HBV-transgenic (HBV-Tg) mice were produced via the microinjection of pAAV/HBV1.2 (genotype Ae) into the embryos of male C57BL/6 mice. Male HBV-Tg and C57BL/6 mice were administered peanut oil or 5 mg/kg of AFB1 dissolved in peanut oil by intraperitoneal injection on the first, fourth and seventh day for a total three injections.
| Gene expression omnibus (GEO) data analysis
Gene expression data of HBV-infected patients were searched from GEO database (http://www.ncbi.nlm.nih.gov/geo/). The relative gene expressions of DNM1L, PTGS2 and MLKL were analysed as previously described. 15 Correlations between the expression of DNM1L
and PTGS2, as well as PTGS2 and MLKL, were evaluated by Pearson's correlation analysis (SPSS, IL).
| Immunofluorescence (IF) and immunohistochemistry (IHC) analysis
For mitochondria morphology, the cells were incubated with 100 nmol/L MitoTracker Red (Thermo Scientific, MA) for 30 min at 37°C. Fluorescence images of cells were obtained with a laserscanning confocal microscope (Zeiss LSM 780, Jena, Germany).
Mitochondrial morphological characteristics were quantified by the mitochondrial fragmentation counts as described previously. 
| Proximity ligation assay (PLA)
The protein interaction between COX-2 and RIP3 was determined by PLA using a Duolink® In Situ Detection Reagents (Sigma-Aldrich) as previously described (Supporting information: Material and methods). 
| Lipid index assays
The liver sections of mice were stained by Oil-Red-O (Jiancheng, Nanjing, China) to visualize LDs and the quantification was performed using IPP 6.0 software. The lipid content in cultured cells were also visualized and quantified using Oil-Red-O staining. In addition, lipids in the liver of mice were extracted and the hepatic TG and total cholesterol (TC) were measured using commercial kits (Jiancheng) according to the manufacturer's instructions.
| Western blot analysis
The livers and the cells were harvested and lysed using radio im- 
| RNA extraction and quantity real-time PCR (qRT-PCR)
Total RNA was extracted using TRIzol reagent (Takara, Osaka, Japan)
and was reverse transcribed with Prime ScriptTM RT reagent kit (Takara). qRT-PCR was then performed with SYBR® Premix Ex Taq™ II Kit (Takara) by CFX96 Touch TM Detection System (Bio-Rad, CA). The primer sequences were listed in Supporting information: Table S1 .
| Statistics
All data were expressed as the mean ± standard deviation (SD). All statistical analyses were conducted with SPSS software v. 16 .0. The differences in data measurements among the groups were analysed initially by a homogeneity test of variances, and then, either an unpaired Student's t test or one-way ANOVA was performed under equivalent conditions. Pearson's correlation analysis was conducted for variables correlation. P < 0.05 was considered to be statistically significant.
| RE SULTS
| Exposure to AFB1 exacerbated lipid droplets (LDs) accumulation in the liver of HBV-Tg mice and HBx-expressing hepatocytes
Based on the Oil-Red-O staining, Figure 1A showed that the amount of LDs was modestly increased in the liver tissues of HBV-Tg mice compared with those in wildtype (WT) mice; and significantly higher levels of LDs were observed in the liver of HBV-Tg mice exposed to AFB1 than those in the unexposed HBV-Tg mice. Meanwhile, hepatic TG and TC contents were increased in the AFB1-exposed WT mice, the HBV-Tg mice, as well as the AFB1-exposed HBV-Tg mice compared with corresponding controls ( Figure 1B , C). Besides animal models, human hepatocytes are the natural target of HBV infection.
HLC mice for HBV infection were constructed and the PHHs were exposed to AFB1 (Supporting information: Figure S1 ). Figure 1D showed that LDs were increased in AFB1-exposed Data were represented by mean ± SD. n = 3. *P < 0.05 compared with unexposed cells or WT mice. # P < 0.05 compared with HBx-expressing cells or HBV-Tg mice. † P < 0.05 compared with AFB1-exposed cells or AFB1-exposed WT mice
| Drp1-dependent mitochondrial dynamics abnormalities regulated HBx and AFB1-induced hepatic steatosis
Given that mitochondrial dysfunction is a key mediator of hepatic lipid metabolism, the impact of HBx and AFB1 on mitochondrial morphology and dynamics was investigated. MitoTracker staining showed that the mitochondrial network was broken down and fragmented into short rods or spheres in HepG2-Tet-ON-HBx cells when HBx were switched on by DOX (Figure 2A,B) . Mitochondrial fragmentation was further aggravated after AFB1 exposure in these HBx-expressing HepG2-Tet-ON-HBx cells (Figure 2A,B) . Mitochondrial fragmentation could be results of activated fission, suppressed fusion or both. 
| COX-2 regulated hepatic steatosis via mitochondrial dynamics remodeling in AFB1-treated HBV-Tg mice and HBx-expressing hepatocytes
The role of COX-2 in HBV-related mitochondrial dynamics abnormalities was investigated. Genomic expression data set of HBV infected patient were employed to explore the relationship among expression of DNM1L, PTGS2 and HBV infection. Figure 3A ,B showed that higher mRNA levels of DNM1L and PTGS2 was shown in the liver biopsy of HBV-infected patient tissues (n = 122) compared with those in normal tissues (n = 6). Moreover, there was a significant correlation (r = 0.5116, P < 0.0001) between expression of DNM1L and PTGS2 in these samples ( Figure 3C ). Figure 3D ,E showed that protein levels of Cox-2 was increased in the liver of both AFB1-exposed mice and Taken together, COX-2 was critical in mediating Drp1-dependent mitochondrial fission during HBx and AFB1-induced hepatic steatosis.
| HBx and AFB1-induced steatosis was associated with the formation of necrosome
Mitochondrial dynamics imbalance has been reported to be involved in cell apoptosis, necroptosis, or other regulatory cell death. 
| HBx and AFB1-induced formation of necrosome depended on the COX-2
We showed that HBx and AFB1-triggerd mitochondrial dynamics abnormalities could be downstream of COX-2 and necrosome formation on mitochondria, but whether COX-2 was involved in the formation of necrosome remained unclear. Figure 5A showed that the mRNA expression of MLKL was higher in the liver of HBV-infected patient than those in normal tissues, and moreover, the expression of MLKL was positively correlated with PTGS2 ( Figure 5B ), suggesting that COX-2 might have a role in regulation of necrosome formation. 
| D ISCUSS I ON
HBV is a small hepatotropic DNA virus responsible for some chronic liver diseases in humans, but the role of HBV infection in the fatty liver diseases remains controversial. 3, 4, 26 In this study, together with previous animals and cellular data, this study showed an effect of AFB1 on exacerbation of HBx-related hepatic steatosis. AFB1 alone has been suggested as a risk factor for NAFLD. 6, 27 Human are exposed to AFB1 mainly through contaminated food, especially corns, peanuts and rice. After ingestion, AFB1
is activated by cytochrome P450 within the liver microsome system to produce large amount of toxic metabolite. 28, 29 HBV infection has been reported to facilitate metabolism and bioactivation of AFB1 in the liver via the transactivation of pregnane X receptor (PXR) and induction in CYP3A4. 30, 31 Moreover, HBV originating from chronic hepatitis or the virus itself could exacerbate host response to AFB1
and down-regulated detoxification-related proteins, 32-34 making HBV-infected hepatocytes more susceptible to AFB1 toxicity.
Instead, exposure to AFB1 would also exacerbate and accelerate the disease progression of HBV infection, perhaps via affecting susceptibility to infection or viral replication. 35 In tropical and humid area such as Southern China, many people are chronically infected with HBV while also exposing AFB1 in their diet. 7 Individuals with HBV infection were much more susceptible to AFB1-associated HCC risk compared with those without these aetiological factors. tissues from patients with chronic liver diseases. 37 The imbalance of fusion and fission homoeostasis is one of the important determinant of mitochondrial function. 38 In this study, co-exposure to HBx and AFB1 increased mitochondrial fragmentation in HepG2-Tet-ON-HBx cells, implying changes in mitochondrial dynamics. For the question of how HBx and AFB1 activated Drp1, our previous investigation into mechanisms of the stemness of nasopharyngeal carcinoma showed that COX-2 increased the activation of Drp1 by recruiting the mitochondrial translocation of p53.
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COX-2 is a key enzyme in the synthesis of prostaglandins and its expression has been reported to be widely up-regulated in multiple human cancers, including colorectal cancers, 39 prostate cancers, 40 gastric cancers 41 and pancreatic cancers, 42 etc, In line with the high expression identified in cancer pathogenesis, this study found that transcription of PTGS2 gene was up-regulated in a GEO cohort of HBV-infected patients. Moreover, both the mRNA and protein level of COX-2 were increased in the HBx and AFB1 co-exposed hepatocytes in vitro, the HBV-infected and AFB1-exposed PHHs in HLC mice ex vivo, and the liver of AFB1-treated HBV-Tg mice in vivo. It was reported that the expression of COX-2 was extremely low in normal liver, 43 but was increased under pathological conditions such as acute liver failure, 44 hepatic fibrosis and cirrhosis, 45 and hepatocarcinogenesis. 43 To date, the implication of COX-2 in hepatic steatosis remains controversial. It was reported that COX-2 transgenetic mice on a high-fat diet exhibited reduction in hepatic steatosis and enhancement of insulin sensitivity and glucose tolerance compared with corresponding wild type mice. 46 implicated in FA β-oxidation when COX-2 was knocked down by siPTGS2 or CRISPR/Cas9 system (Supporting information: Figure   S2 ), which occurred in parallel to the reduction in LDs.
Drp1-associated mitochondrial fragmentation is a required step for execution of apoptosis and necroptosis. 49, 50 In this study, combined exposure to AFB1 decreased cell viability in all three
HBx-expressing hepatocytes (Supporting information: Figure   S3 ). system. Therefore, COX-2 could recruit RIP3 to mitochondria.
Most importantly, we verified that RIP3 was in close proximity with COX-2 on mitochondria in HBx and AFB1-exposed HepG2-Tet-ON-HBx cells and HepG2 cells (Supporting information: Figure S4 ). Moreover, co-precipitated p-MLKL and RIP3 were significantly reduced after COX-2 was decreased by siPTGS2.
These data elucidated that knockdown of COX-2 protected HBx and AFB1 co-exposed hepatocytes from necroptosis via suppressing necrosome formation on mitochondria. In addition, we further confirmed that Drp1-related mitochondrial dynamics abnormalities were also the downstream mediators of necrosome formation during the process of LDs accumulation in HBx and AFB1-co-exposed hepatocytes. This is the first study reporting the pivotal role of COX-2 in regulation of necrosome formation and Drp1-mediated mitochondrial fragmentation during HBx and AFB1-induced hepatic steatosis. Therefore, pharmacological modification and genetic intervention targeted at COX-2 activity seems to be a potential therapeutic strategy counteracting HBV infection and/or AFB1 exposure-related hepatic steatosis, as well as hepatic diseases associated with necrotic cell death.
Taken together, exposure to AFB1, combined with HBx, increased risk of hepatic steatosis. Owing to the up-regulation of COX-2, coexposure to HBx and AFB1 promoted the formation of RIP3-MLKL necrosome and induced Drp-1-mediated mitochondrial fragmentation and dysfunction in the hepatocytes, finally contributing to the LDs accumulation ( Figure 6 ). COX-2 could be a target molecular for developing agents for prevention and therapy to the inducible mitochondria-associated hepatic necroptosis and/or NAFLD.
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